Technical Support
(877) SEPAX-US, press 3 TechSupport@sepax-tech.com |
|
Sample: Fusion ProteinFusion Protein Recommended products
Size Exclusion:
Zenix
Zenix-C
SRT
SRT-C
Preparative SEC
Ion Exchange: Proteomix Antibodix Reversed phase: Proteomix RP Bio-C4 |
Application Note
Featured Application Notes
All Application Notes
App ID | Title |
LR2024081527 | Literature Reference: Universal Paramyxovirus Vaccine Design by Stabilizing Regions Involved in Structural Transformation of the Fusion Protein |
EP1004 | Fusion Protein Separation on SEC and SAX |
LR20220261 | Literature Reference: Characterization of Fc-fusion protein aggregates derived from extracellular domain disulfide bond rearrangements |
PP1026 | Fc Fusion Protein Separation on Sepax Proteomix SAX Columns |
WP1001 | Fusion Protein Enbrel Separation on Unix-C UHPLC SEC Column |
HICP1001 | HICP1001 - Fusion protein Analysis on Proteomix® HICBu-NP5 ( 4603 ) |
PP1021 | HSA Fusion Protein Analysis on Proteomix SAX |
EP1003 | HSA Fusion Protein Separation on Zenix and Zenix-C 300 |
EP1001 | Fusion Protein Separation on Zenix and Zenix-C 300 |
ZP1009 | Analysis of Fc Fusion Protein on Zenix vs. SRT |